Review



ccl28 pa5–28821  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Thermo Fisher ccl28 pa5–28821
    Ccl28 Pa5–28821, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ccl28+pa5%E2%80%9328821/pm39440906-39-15-20
    Average 90 stars, based on 1 article reviews
    ccl28 pa5–28821 - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Immunohistochemistry:

    Article Title: FOXP3 +/ CD8 + ratio associated with aggressive behavior in RUNX3 ‐methylated diffuse esophagogastric junction tumor
    Article Snippet: IHC staining for Ki‐67, HER2, and PD‐L1 was performed as previously described, and IHC for CCL28 (clone PA5–28821, Invitrogen) was performed in a similar manner.

    Article Title: FOXP3+/CD8+ ratio associated with aggressive behavior in RUNX3-methylated diffuse esophagogastric junction tumor.
    Article Snippet: IHC staining for Ki- 67, HER2, and PD- L1 was performed as previously described, and IHC for CCL28 (clone PA5–28821, Invitrogen) was performed in a similar manner.25 PDL1 expression was quantified using tumor proportion score (TPS), and positive PD- L1 expression was defined as TPS ≥1%.28 Multiplex fluorescence IHC for CCL28, CK, and FOXP3 was also employed and scanned by Vectra Polaris (AKOYA Biosciences) as previously described.29 2.3 | Calculating FOXP3+/CD8+ at the invasive margin or intratumor Three hotspots enriched with lymphocytes were selected at the invasive margin or the intratumoral region on H&E- stained sections.

    Staining:

    Article Title: FOXP3 +/ CD8 + ratio associated with aggressive behavior in RUNX3 ‐methylated diffuse esophagogastric junction tumor
    Article Snippet: IHC staining for Ki‐67, HER2, and PD‐L1 was performed as previously described, and IHC for CCL28 (clone PA5–28821, Invitrogen) was performed in a similar manner.

    Article Title: FOXP3+/CD8+ ratio associated with aggressive behavior in RUNX3-methylated diffuse esophagogastric junction tumor.
    Article Snippet: IHC staining for Ki- 67, HER2, and PD- L1 was performed as previously described, and IHC for CCL28 (clone PA5–28821, Invitrogen) was performed in a similar manner.25 PDL1 expression was quantified using tumor proportion score (TPS), and positive PD- L1 expression was defined as TPS ≥1%.28 Multiplex fluorescence IHC for CCL28, CK, and FOXP3 was also employed and scanned by Vectra Polaris (AKOYA Biosciences) as previously described.29 2.3 | Calculating FOXP3+/CD8+ at the invasive margin or intratumor Three hotspots enriched with lymphocytes were selected at the invasive margin or the intratumoral region on H&E- stained sections.

    Expressing:

    Article Title: FOXP3 +/ CD8 + ratio associated with aggressive behavior in RUNX3 ‐methylated diffuse esophagogastric junction tumor
    Article Snippet: IHC staining for Ki‐67, HER2, and PD‐L1 was performed as previously described, and IHC for CCL28 (clone PA5–28821, Invitrogen) was performed in a similar manner.

    Article Title: FOXP3+/CD8+ ratio associated with aggressive behavior in RUNX3-methylated diffuse esophagogastric junction tumor.
    Article Snippet: IHC staining for Ki- 67, HER2, and PD- L1 was performed as previously described, and IHC for CCL28 (clone PA5–28821, Invitrogen) was performed in a similar manner.25 PDL1 expression was quantified using tumor proportion score (TPS), and positive PD- L1 expression was defined as TPS ≥1%.28 Multiplex fluorescence IHC for CCL28, CK, and FOXP3 was also employed and scanned by Vectra Polaris (AKOYA Biosciences) as previously described.29 2.3 | Calculating FOXP3+/CD8+ at the invasive margin or intratumor Three hotspots enriched with lymphocytes were selected at the invasive margin or the intratumoral region on H&E- stained sections.

    Multiplex Assay:

    Article Title: FOXP3 +/ CD8 + ratio associated with aggressive behavior in RUNX3 ‐methylated diffuse esophagogastric junction tumor
    Article Snippet: IHC staining for Ki‐67, HER2, and PD‐L1 was performed as previously described, and IHC for CCL28 (clone PA5–28821, Invitrogen) was performed in a similar manner.

    Article Title: FOXP3+/CD8+ ratio associated with aggressive behavior in RUNX3-methylated diffuse esophagogastric junction tumor.
    Article Snippet: IHC staining for Ki- 67, HER2, and PD- L1 was performed as previously described, and IHC for CCL28 (clone PA5–28821, Invitrogen) was performed in a similar manner.25 PDL1 expression was quantified using tumor proportion score (TPS), and positive PD- L1 expression was defined as TPS ≥1%.28 Multiplex fluorescence IHC for CCL28, CK, and FOXP3 was also employed and scanned by Vectra Polaris (AKOYA Biosciences) as previously described.29 2.3 | Calculating FOXP3+/CD8+ at the invasive margin or intratumor Three hotspots enriched with lymphocytes were selected at the invasive margin or the intratumoral region on H&E- stained sections.

    Fluorescence:

    Article Title: FOXP3 +/ CD8 + ratio associated with aggressive behavior in RUNX3 ‐methylated diffuse esophagogastric junction tumor
    Article Snippet: IHC staining for Ki‐67, HER2, and PD‐L1 was performed as previously described, and IHC for CCL28 (clone PA5–28821, Invitrogen) was performed in a similar manner.

    Article Title: FOXP3+/CD8+ ratio associated with aggressive behavior in RUNX3-methylated diffuse esophagogastric junction tumor.
    Article Snippet: IHC staining for Ki- 67, HER2, and PD- L1 was performed as previously described, and IHC for CCL28 (clone PA5–28821, Invitrogen) was performed in a similar manner.25 PDL1 expression was quantified using tumor proportion score (TPS), and positive PD- L1 expression was defined as TPS ≥1%.28 Multiplex fluorescence IHC for CCL28, CK, and FOXP3 was also employed and scanned by Vectra Polaris (AKOYA Biosciences) as previously described.29 2.3 | Calculating FOXP3+/CD8+ at the invasive margin or intratumor Three hotspots enriched with lymphocytes were selected at the invasive margin or the intratumoral region on H&E- stained sections.

    Methylation:

    Article Title: FOXP3 +/ CD8 + ratio associated with aggressive behavior in RUNX3 ‐methylated diffuse esophagogastric junction tumor
    Article Snippet: IHC staining for Ki‐67, HER2, and PD‐L1 was performed as previously described, and IHC for CCL28 (clone PA5–28821, Invitrogen) was performed in a similar manner.

    Article Title: FOXP3+/CD8+ ratio associated with aggressive behavior in RUNX3-methylated diffuse esophagogastric junction tumor.
    Article Snippet: IHC staining for Ki- 67, HER2, and PD- L1 was performed as previously described, and IHC for CCL28 (clone PA5–28821, Invitrogen) was performed in a similar manner.25 PDL1 expression was quantified using tumor proportion score (TPS), and positive PD- L1 expression was defined as TPS ≥1%.28 Multiplex fluorescence IHC for CCL28, CK, and FOXP3 was also employed and scanned by Vectra Polaris (AKOYA Biosciences) as previously described.29 2.3 | Calculating FOXP3+/CD8+ at the invasive margin or intratumor Three hotspots enriched with lymphocytes were selected at the invasive margin or the intratumoral region on H&E- stained sections.

    Virus:

    Article Title: FOXP3 +/ CD8 + ratio associated with aggressive behavior in RUNX3 ‐methylated diffuse esophagogastric junction tumor
    Article Snippet: IHC staining for Ki‐67, HER2, and PD‐L1 was performed as previously described, and IHC for CCL28 (clone PA5–28821, Invitrogen) was performed in a similar manner.

    Article Title: FOXP3+/CD8+ ratio associated with aggressive behavior in RUNX3-methylated diffuse esophagogastric junction tumor.
    Article Snippet: IHC staining for Ki- 67, HER2, and PD- L1 was performed as previously described, and IHC for CCL28 (clone PA5–28821, Invitrogen) was performed in a similar manner.25 PDL1 expression was quantified using tumor proportion score (TPS), and positive PD- L1 expression was defined as TPS ≥1%.28 Multiplex fluorescence IHC for CCL28, CK, and FOXP3 was also employed and scanned by Vectra Polaris (AKOYA Biosciences) as previously described.29 2.3 | Calculating FOXP3+/CD8+ at the invasive margin or intratumor Three hotspots enriched with lymphocytes were selected at the invasive margin or the intratumoral region on H&E- stained sections.

    Immunohistochemical staining:

    Article Title: FOXP3 +/ CD8 + ratio associated with aggressive behavior in RUNX3 ‐methylated diffuse esophagogastric junction tumor
    Article Snippet: IHC staining for Ki‐67, HER2, and PD‐L1 was performed as previously described, and IHC for CCL28 (clone PA5–28821, Invitrogen) was performed in a similar manner.

    Article Title: FOXP3+/CD8+ ratio associated with aggressive behavior in RUNX3-methylated diffuse esophagogastric junction tumor.
    Article Snippet: IHC staining for Ki- 67, HER2, and PD- L1 was performed as previously described, and IHC for CCL28 (clone PA5–28821, Invitrogen) was performed in a similar manner.25 PDL1 expression was quantified using tumor proportion score (TPS), and positive PD- L1 expression was defined as TPS ≥1%.28 Multiplex fluorescence IHC for CCL28, CK, and FOXP3 was also employed and scanned by Vectra Polaris (AKOYA Biosciences) as previously described.29 2.3 | Calculating FOXP3+/CD8+ at the invasive margin or intratumor Three hotspots enriched with lymphocytes were selected at the invasive margin or the intratumoral region on H&E- stained sections.



    Similar Products

    ccl28 pa5–28821  (Thermo Fisher)
    90
    Thermo Fisher ccl28 pa5–28821
    Ccl28 Pa5–28821, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ccl28+pa5%E2%80%9328821/pm39440906-39-15-20
    Average 90 stars, based on 1 article reviews
    ccl28 pa5–28821 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results